Global Daptomycin Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Daptomycin

• 1.1 Definition of Daptomycin
• 1.2 Daptomycin Segment by Type
  • 1.2.1 Global Daptomycin Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 350 mg lyophilized powder
  • 1.2.3 500 mg lyophilized powder
• 1.3 Daptomycin Segment by Applications
  • 1.3.1 Global Daptomycin Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Adult
  • 1.3.3 Pediatric patients (1 to 17 years of age)
• 1.4 Global Daptomycin Overall Market
  • 1.4.1 Global Daptomycin Revenue (2014-2025)
  • 1.4.2 Global Daptomycin Production (2014-2025)
  • 1.4.3 North America Daptomycin Status and Prospect (2014-2025)
  • 1.4.4 Europe Daptomycin Status and Prospect (2014-2025)
  • 1.4.5 China Daptomycin Status and Prospect (2014-2025)
  • 1.4.6 Japan Daptomycin Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Daptomycin Status and Prospect (2014-2025)
  • 1.4.8 India Daptomycin Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Daptomycin
• 2.3 Manufacturing Process Analysis of Daptomycin
• 2.4 Industry Chain Structure of Daptomycin

3 Development and Manufacturing Plants Analysis of Daptomycin

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Daptomycin Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Daptomycin
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Daptomycin Production and Capacity Analysis
• 4.2 Daptomycin Revenue Analysis
• 4.3 Daptomycin Price Analysis
• 4.4 Market Concentration Degree

5 Daptomycin Regional Market Analysis

• 5.1 Daptomycin Production by Regions
  • 5.1.1 Global Daptomycin Production by Regions
  • 5.1.2 Global Daptomycin Revenue by Regions
• 5.2 Daptomycin Consumption by Regions
• 5.3 North America Daptomycin Market Analysis
  • 5.3.1 North America Daptomycin Production
  • 5.3.2 North America Daptomycin Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Daptomycin Import and Export
• 5.4 Europe Daptomycin Market Analysis
  • 5.4.1 Europe Daptomycin Production
  • 5.4.2 Europe Daptomycin Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Daptomycin Import and Export
• 5.5 China Daptomycin Market Analysis
  • 5.5.1 China Daptomycin Production
  • 5.5.2 China Daptomycin Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Daptomycin Import and Export
• 5.6 Japan Daptomycin Market Analysis
  • 5.6.1 Japan Daptomycin Production
  • 5.6.2 Japan Daptomycin Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Daptomycin Import and Export
• 5.7 Southeast Asia Daptomycin Market Analysis
  • 5.7.1 Southeast Asia Daptomycin Production
  • 5.7.2 Southeast Asia Daptomycin Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Daptomycin Import and Export
• 5.8 India Daptomycin Market Analysis
  • 5.8.1 India Daptomycin Production
  • 5.8.2 India Daptomycin Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Daptomycin Import and Export

6 Daptomycin Segment Market Analysis (by Type)

• 6.1 Global Daptomycin Production by Type
• 6.2 Global Daptomycin Revenue by Type
• 6.3 Daptomycin Price by Type

7 Daptomycin Segment Market Analysis (by Application)

• 7.1 Global Daptomycin Consumption by Application
• 7.2 Global Daptomycin Consumption Market Share by Application (2014-2019)

8 Daptomycin Major Manufacturers Analysis

• 8.1 Merck & Co.
  • 8.1.1 Merck & Co. Daptomycin Production Sites and Area Served
  • 8.1.2 Merck & Co. Product Introduction, Application and Specification
  • 8.1.3 Merck & Co. Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Pfizer
  • 8.2.1 Pfizer Daptomycin Production Sites and Area Served
  • 8.2.2 Pfizer Product Introduction, Application and Specification
  • 8.2.3 Pfizer Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Teva
  • 8.3.1 Teva Daptomycin Production Sites and Area Served
  • 8.3.2 Teva Product Introduction, Application and Specification
  • 8.3.3 Teva Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Mylan
  • 8.4.1 Mylan Daptomycin Production Sites and Area Served
  • 8.4.2 Mylan Product Introduction, Application and Specification
  • 8.4.3 Mylan Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Fresenius Kabi
  • 8.5.1 Fresenius Kabi Daptomycin Production Sites and Area Served
  • 8.5.2 Fresenius Kabi Product Introduction, Application and Specification
  • 8.5.3 Fresenius Kabi Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sagent Pharmaceuticals
  • 8.6.1 Sagent Pharmaceuticals Daptomycin Production Sites and Area Served
  • 8.6.2 Sagent Pharmaceuticals Product Introduction, Application and Specification
  • 8.6.3 Sagent Pharmaceuticals Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Xellia
  • 8.7.1 Xellia Daptomycin Production Sites and Area Served
  • 8.7.2 Xellia Product Introduction, Application and Specification
  • 8.7.3 Xellia Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Hisun
  • 8.8.1 Hisun Daptomycin Production Sites and Area Served
  • 8.8.2 Hisun Product Introduction, Application and Specification
  • 8.8.3 Hisun Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 HENGRUI PHARMA
  • 8.9.1 HENGRUI PHARMA Daptomycin Production Sites and Area Served
  • 8.9.2 HENGRUI PHARMA Product Introduction, Application and Specification
  • 8.9.3 HENGRUI PHARMA Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Huadong Medicine
  • 8.10.1 Huadong Medicine Daptomycin Production Sites and Area Served
  • 8.10.2 Huadong Medicine Product Introduction, Application and Specification
  • 8.10.3 Huadong Medicine Daptomycin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Daptomycin Market

• 9.1 Global Daptomycin Market Trend Analysis
  • 9.1.1 Global Daptomycin Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Daptomycin Regional Market Trend
  • 9.2.1 North America Daptomycin Forecast 2019-2025
  • 9.2.2 Europe Daptomycin Forecast 2019-2025
  • 9.2.3 China Daptomycin Forecast 2019-2025
  • 9.2.4 Japan Daptomycin Forecast 2019-2025
  • 9.2.5 Southeast Asia Daptomycin Forecast 2019-2025
  • 9.2.6 India Daptomycin Forecast 2019-2025
• 9.3 Daptomycin Market Trend (Product Type)
• 9.4 Daptomycin Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Daptomycin Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List